Transformation from inflamed skin to clear skin, symbolizing healing and hope.

Unlocking Clear Skin: The Latest Breakthroughs in Psoriasis and Rosacea Treatments

Soraya Malik in Health & Wellness August 2025 • 4 min read.

"Discover how new systemic treatments and patient-focused initiatives are revolutionizing care for psoriasis and rosacea sufferers."

Living with psoriasis or rosacea can feel like a constant battle. These chronic skin conditions not only affect physical appearance but can also impact self-esteem and overall quality of life. Fortunately, ongoing research and patient advocacy are paving the way for more effective and compassionate care.

For individuals with psoriasis, new targeted medications offer hope for clearer skin and lasting relief. Simultaneously, initiatives like the 'Aktiv gegen Rosacea' campaign are empowering patients to take control of their skin health journey.

This article delves into the latest breakthroughs in psoriasis and rosacea treatments, providing insights into innovative systemic therapies, the importance of patient education, and practical tips for managing these conditions.

Revolutionizing Psoriasis Treatment: The Power of Targeted Therapies

Transformation from inflamed skin to clear skin, symbolizing healing and hope.

Traditional approaches to managing moderate to severe psoriasis often involve topical treatments and conventional systemic medications. While these options can be effective for some, they may not provide adequate relief for everyone. New targeted medications, known as biologics, are transforming the treatment landscape.

One such biologic, Brodalumab (Kyntheum®), represents a significant advancement in psoriasis care. Unlike other biologics that target the cytokine IL-17A, Brodalumab selectively blocks the receptor subunit A of the IL-17 receptor. This unique mechanism of action inhibits multiple IL-17 isoforms (IL-17A, IL-17A/F, IL-17F, IL-17C, and IL-17E), which are implicated in the development of psoriasis.

Faster Results: Clinical trials have demonstrated that Brodalumab leads to significantly faster skin clearance compared to other treatments like ustekinumab.
Higher Clearance Rates: More patients achieved complete or near-complete skin clearance (PASI 100) with Brodalumab compared to ustekinumab.
Sustained Relief: The benefits of Brodalumab have been shown to last for up to 52 weeks, providing long-term relief from psoriasis symptoms.

Dr. Ralph von Kiedrowski highlights that if conventional systemic therapies don't yield satisfactory results, a biologic, such as Brodalumab, can be considered earlier in the treatment plan. The data indicate a significant improvement in outcomes for many patients, but individual results can vary. Discussing potential treatments and their suitability with a healthcare provider is essential.

Empowering Patients Through Education and Support

Whether you're dealing with psoriasis or rosacea, remember that you're not alone. By staying informed, seeking professional care, and connecting with others, you can take control of your skin health and live a happier, healthier life. The advancements in treatment options and the availability of patient support make it an opportune time to seek personalized solutions and embrace a proactive approach to skincare.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is Brodalumab and how does it work to treat psoriasis?

Brodalumab (Kyntheum®) is a biologic medication used to treat psoriasis. It works by selectively blocking the receptor subunit A of the IL-17 receptor. This action inhibits multiple IL-17 isoforms (IL-17A, IL-17A/F, IL-17F, IL-17C, and IL-17E), which are involved in the development of psoriasis, leading to skin clearance and symptom relief. Brodalumab's unique mechanism of action differentiates it from other biologics and contributes to its effectiveness in treating psoriasis.

What are the advantages of Brodalumab over other treatments like Ustekinumab?

Clinical trials have shown that Brodalumab offers several advantages compared to treatments like ustekinumab. Brodalumab leads to faster skin clearance and higher clearance rates, with more patients achieving complete or near-complete skin clearance (PASI 100). Furthermore, the benefits of Brodalumab have been shown to last for up to 52 weeks, providing sustained relief from psoriasis symptoms. This makes Brodalumab a promising option for long-term psoriasis management.

When should someone consider using Brodalumab for psoriasis?

Dr. Ralph von Kiedrowski suggests that if conventional systemic therapies do not provide satisfactory results for psoriasis, a biologic like Brodalumab should be considered earlier in the treatment plan. This approach recognizes the limitations of traditional treatments and highlights the potential for improved outcomes with Brodalumab for individuals who do not respond adequately to conventional methods.

Beyond medication, what else can individuals with psoriasis or rosacea do to improve their skin health?

Individuals with psoriasis or rosacea can take proactive steps to improve their skin health beyond medication. This includes staying informed about the latest treatments, seeking professional care from healthcare providers, and connecting with others who have similar conditions. The 'Aktiv gegen Rosacea' campaign and other patient support initiatives emphasize the importance of education and support in empowering individuals to manage their conditions effectively. Embracing a proactive approach to skincare and seeking personalized solutions are also key.

How does patient support impact the management of rosacea and psoriasis?

Patient support plays a crucial role in managing rosacea and psoriasis by providing individuals with information, resources, and a sense of community. Campaigns such as 'Aktiv gegen Rosacea' offer educational materials, promoting self-management strategies and fostering a supportive environment. Advancements in treatment options combined with comprehensive patient support programs empower individuals to take control of their skin health, improving their quality of life and overall well-being. This support helps individuals stay informed, seek professional care, and connect with others, creating a more effective approach to managing these chronic skin conditions.